22 research outputs found

    ๊ฐ€์ž…๋น„๋ฅผ ๋ถ€๊ณผํ•˜๋Š” ์–‘๋ฉด์‹œ์žฅ์—์„œ ํ”Œ๋žซํผ ์ˆ˜์ต์— ์˜ํ–ฅ์„ ์ฃผ๋Š” ์ฃผ์š”์ธ๋“ค์— ๋Œ€ํ•œ ์—ฐ๊ตฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ๊ฒฝ์˜ํ•™๊ณผ, 2014. 2. ์˜ค์ •์„.In many of two-sided market studies, network externality has been the most attention receiving variable. Li et al. suggested in their work that if platform does not differentiate itself enough, attempt to increase network externality could actually harm platforms profit. In this work, a model was designed to accommodate buyer side access fee, which was not considered in Li et al.s model. Examining newly constructed model, several implications are derived. There are difference makers in each of optimization casesalso no-difference makers. Moreover access fee differences cause uncertainties that are possible to control with platforms access fees for either seller or buyer. Furthermore the finding of common no-difference maker could free platforms from what these no-difference makers represent. Also application of the results to case of professional SNS shows access fee discount of certain platform could be an unnecessary discount. This paper contribute to two-sided market study by providing hints of where to allocate its resource and where not toalso gives shows how each of variables are related and even interacts (particularly seller side access fee and buyer side access fee). Furthermore, the study verifies result of Li et al.s study and shows their result might be lack of generality.1. Introduction 2. Literature Review 3. Model 4. Analysis and Results 4.1. Optimized to Seller Side Access Fee case one 4.2. Optimized to Seller Side Access Fee case two 4.3. Optimized to Buyer Side Access Fee case one 4.4. Optimized to Buyer Side Access Fee case two 4.5. Summary of Analysis 4.6. Case - Professional Social Network Services 5. Conclusion 5.1 Conclusion 5.2 Limitations and suggestions References Appendix ๊ตญ๋ฌธ์ดˆ๋กMaste

    Repetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinoma

    Get PDF
    BACKGROUND: Hepatic arterial infusion chemotherapy (HAIC) has often been selected as a therapeutic option for patients with advanced hepatocellular carcinoma (HCC). The objective of the current study was to evaluate the efficacy and safety of repetitive HAIC with high-dose 5-fluorouracil (5-FU) and cisplatin given for 3 days in patients with advanced HCC. METHODS: Between January 2001 and December 2004, a total of 41 patients with unresectable advanced HCC were enrolled. The patients underwent HAIC via the implantable port system with 5-FU (at a dose of 500 mg/m(2) on Days 1-3) and cisplatin (at a dose of 60 mg/m(2) on Day 2) every 4 weeks. Tumor response was assessed at the end of every 3 cycles. RESULTS: The median age of the patients was 53 years and 34 patients (82.9%) had evidence of portal vein thrombosis. In total, 230 cycles of HAIC were administered to the 41 patients, with a median of 6 cycles given (range, 1-14 cycles). Nine patients (22.0%) achieved a partial response and 14 patients (34.1%) had stable disease. The median time to disease progression and overall survival were 7.0 months and 12.0 months, respectively. The overall survival was found to be significantly longer in the successful disease control group (patients with a complete response, partial response, and stable disease) than in the disease progression group (median of 14.0 months vs 6.0 months; P < .001). Adverse reactions were tolerable and successfully managed with conservative treatment. CONCLUSIONS: HAIC with high-dose 5-FU and cisplatin given for 3 days achieved effective and safe results in patients with advanced HCC. Therefore, repetitive short-course HAIC with high-dose 5-FU and cisplatin may be useful as an alternative therapeutic option for patients with advanced HCC.ope

    MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection

    Get PDF
    A single-nucleotide polymorphism (SNP) in the promoter region of MDM2, SNP 309, is associated with hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus infection. The effect of p53 codon 72 polymorphism Arg72Pro on HCC risk remains inconsistent. This study evaluated the association of MDM2 and p53 polymorphisms with the presence and early onset of HCC in Korean patients with chronic hepatitis B virus (HBV) infection. In total, 583 consecutive patients with chronic HBV infection were classified according to the presence (n = 287) or absence (n = 296) of HCC. The MDM2 SNP 309 and p53 Arg72Pro were genotyped using restriction fragment length polymorphism method. The MDM2 G/G and p53 Pro/Pro genotypes were more frequent in HCC group than in non-HCC group (P < 0.001 and P = 0.004, respectively). Multivariate analysis for the presence of HCC revealed that the odds ratio (OR) for MDM2 G/G over T/T was 4.89 (P < 0.001) and that of p53 Pro/Pro over Arg/Arg was 3.03 (P = 0.006). Combined MDM2 G/G and p53 Pro/Pro had a synergistic effect on HCC risk, with an OR of 20.78 (P < 0.001). The mean age of tumor onset in patients with MDM2 G/G genotype was 50.9 years compared with 55.1 with T/T genotype (P = 0.018) and that with p53 Pro/Pro was 49.7 years compared with 52.9 with Arg/Arg (P = 0.040). Thus, MDM2 SNP 309 and p53 Arg72Pro are associated with the early development of HCC in Korean patients with chronic HBV infection.ope

    Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats.

    Get PDF
    Magnesium lithospermate B (MLB) is one of the major active components of Salvia miltiorrhizae. The anti-oxidative effects of Salvia miltiorrhizae have been previously reported. The aim of this study was to investigate the effect of purified MLB on hepatic fibrosis in rats and on the fibrogenic responses in hepatic stellate cells (HSCs). Hepatic fibrosis was induced in rats by intraperitoneal thioacetamide (TAA) injections over a period of 8 or 12 weeks. MLB was orally administered daily by gavage tube. Serum AST and ALT levels in TAA+ MLB group were significantly lower than those in TAA only group at week 8. Hepatic fibrosis was significantly attenuated in TAA+MLB group than in TAA only group at week 8 or 12. Activation of HSCs was also decreased in TAA+MLB group as compared to TAA only group. Hepatic mRNA expression of ฮฑ-smooth muscle actin (ฮฑ-SMA), TGF-ฮฒ1, and collagen ฮฑ1(I) was significantly decreased in TAA+MLB group as compared to TAA only group. Incubation with HSCs and MLB (>or=100 ฮผM) for up to 48 h showed no cytotoxicity. MLB suppressed PDGF-induced HSC proliferation. MLB inhibited NF-ฮšB transcriptional activation and monocyte chemotactic protein 1 (MCP-1) production in HSCs. MLB strongly suppressed H(2)O(2)-induced reactive oxygen species (ROS) generation in HSCs, and MLB inhibited type I collagen secretion in HSCs. We concluded that MLB has potent antifibrotic effect in TAA-treated cirrhotic rats, and inhibits fibrogenic responses in HSCs. These data suggest that MLB has potential as a novel therapy for hepatic fibrosis.ope

    Marathon running may induce a temporary bone loss

    No full text
    This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (grant number 2015R1D1A1A09057878

    ๋งฅ์ง„๊ธฐ(่„ˆ่จบๆฉŸ) ์ œ์ž‘๊ณผ ๋งฅํŒŒ(่„ˆๆณข) ๋ถ„์„

    No full text
    ํ•™์œ„๋…ผ๋ฌธ(์„์‚ฌ)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ณผํ•™๊ต์œก๊ณผ ๋ฌผ๋ฆฌ์ „๊ณต,2000.Maste

    Cost-effectiveness analysis of low sulfur oil application for the air pollution abatement

    No full text
    ํ™˜๊ฒฝ๊ด€๋ฆฌํ•™๊ณผ/์„์‚ฌ[ํ•œ๊ธ€] ็”ฃๆฅญ๊ณผ ใ€€ๆฟŸ์˜ ้ซ˜ๅบฆๆˆ้•ท์— ๋”ฐ๋ฅธ ็”ฃๆฅญ้ซ”์™€ ่‡ชๅ‹•่ปŠ็ญ‰์˜ ๅŒ–็Ÿณ็‡ƒๆ–™ไฝฟ็”จๅขžๅŠ ์™€ ๋”๋ถˆ์–ด ๆœ€่ฟ‘ ์šฐ๋ฆฌ๋‚˜๋ผ ไธป่ฆ้ƒฝๅธ‚์˜ ๅคงๆฐฃๆฑšๆŸ“ๅบฆ๋Š” ๋Œ€๋ถ€๋ถ„ ๆณ•็š„็’ฐๅขƒๅŸบๆบ–ๅ€ค๋ฅผ ๋„˜์–ด์„œ ์žˆ๋‹ค. ์ด์— ็’ฐๅขƒ๊ณผ ๅคงๆฐฃๆฑšๆŸ“์— ้—œ่ฏ๋œ ๆœ€่ฟ‘์˜ ๅ„็จฎ่ณ‡ๆ–™๋ฅผ ่’้›†ๅˆ†ๆžํ•˜์—ฌ ์šฐ๋ฆฌ๋‚˜๋ผ์—์„œ ๊ฐ€์žฅ ๆ•ˆๆžœ็š„์ด๊ณ  ๅฏฆๆ•ˆๆ€ง์žˆ๋Š” ๅคงๆฐฃๆฑšๆŸ“้˜ฒๆญขๅฐ็ญ–์œผ๋กœ ไฝŽๆต้ปƒๆฒนๅฐ็ญ–์ด ๅฏฆ่กŒ๋˜์–ด์งˆ ๊ฒฝ์šฐ ๆžœ์™€ ่ฒป็”จ์— ้—œํ•ด ็ก็ฉถํ•ด ๋ณธ ็ตๆžœ๋Š” ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค. 1. ็พๅœจ์˜ ็‹€ๆ…‹๋กœ ๅ…จๅœ‹์—์„œ ไฝฟ็”จํ•˜๋Š” ่ผ•ๆฒน ๋ฐ B-Cๆฒน์˜ ็กซ้ปƒๅซ๏งŠ้‡์„ ๅ„ๅ„ 60%์”ฉ ๆธ›ๅฐ‘์‹œํ‚จ ไฝŽ็กซ้ปƒๆฒน๋กœ ๅ…จ้‡ไปฃๆ›ฟํ•˜์—ฌ ไพ›็ตฆํ•  ๊ฒฝ์šฐ ๅ…จๅœ‹์˜ ไบž้ปƒ้…ธ๊ฐ€์ŠคๆŽ’ๅ‡บ้‡์€ ็ด„485, ์„œ์šธๅธ‚์˜ ไบž้ปƒ้…ธ๊ฐ€์Šค ๆŽ’ๅ‡บ้‡์€ ็ด„40%๊ฐ€ ๆธ›ๅฐ‘ํ•˜๊ฒŒ ๋  ๊ฒƒ์œผ๋กœ ๆŽจ่จˆ๋œ๋‹ค. 2. ์„œ์šธๅธ‚์—์„œ ๅ‰่ฟฐํ•œ ไฝŽ็กซ้ปƒๆฒนๅฐ็ญ–์„ ๅฏฆ่กŒํ•  ๊ฒฝ์šฐ 80ๅนดๅบฆ์˜ ๏ฆŽๅนณๅ‡ ไบž้ปƒ้…ธ๊ฐ€์ŠคๆฑšๆŸ“ๅบฆ์˜€๋˜ 0.094ppm์€ 0.056ppm๊นŒ์ง€ ๆธ›ๅฐ‘์‹œํ‚ฌ ์ˆ˜ ์žˆ์„ ๊ฒƒ์œผ๋กœ ๆŽจ่จˆ๋œ๋‹ค. ๋”ฐ๋ผ์„œ ๆณ•็š„็’ฐๅขƒๅŸบๆบ–ๅ€ค๋ฅผ ๆŽจๆŒํ•˜๊ธฐ ็ˆฒํ•ด์„œ๋Š” ็Ÿณ็‚ญไฝฟ็”จ้‡์˜ 50%๋ฅผ ไฝŽ็กซ้ปƒ่ผ•ๆฒน๋กœ ไปฃๆ›ฟํ•ด์•ผ ํ•  ๊ฒƒ์œผ๋กœ ๆŽจ่จˆ๋œ๋‹ค. 3. ไฝŽ็กซ้ปƒๆฒนๅฐ็ญ–์„ ๅฏฆ่กŒํ•  ๊ฒฝ์šฐ ๆฏๅนด ่ฒป็”จๅขžๅŠ ็ธฝ้ก์€ 83ๅนด์— 1,425.1ๅ„„์›, 84ๅนด์— 1,423.9ๅ„„์›, 85ๅนด์— 1,136ๅ„„์›, 86ๅนด์— 1,396.9ๅ„„์›์ด ๋  ๊ฒƒ์œผ๋กœ ๆŽจ็ฎ—๋˜์—ˆ๋‹ค. ็‰นํžˆ, ์šฐ๋ฆฌ๋‚˜๋ผ ไบž้ปƒ้…ธ๊ฐ€์Šค ๅ…จๅ€ๅ‡บ้‡์˜ 75%๊ฐ€ B-Cๆฒน๋กœ๋ถ€ํ„ฐ ๆŽ’ๅ‡บ๋˜์–ด์˜จ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚˜, ็พๅœจ ไฝฟ็”จ๋˜๊ณ  ์žˆ๋Š” ้ซ˜็กซ้ปƒB-Cๆฒน์˜ ไฝŽ๏งŽ้ปƒๅŒ–๋Š” ๋”์šฑ์ด ์‹œ๊ธ‰ํ•œ ์‹ค์ •์ด๋ผ ํ•˜๊ฒ ๋‹ค. [์˜๋ฌธ] Recently, the air pollution in the main cities in Korea is over the legal envitonmental criteria,Especially sulfur dioxide pollution is serious because of growing usage of fossil fuel. About the low sulfur oil usage policy in Korea, the cost effectiveness analysis were performed with the various recent data related to air pollution. The results were as follows. 1. Low sulfur Bunker-C oil (1.6%S), and Light oil (0.4%S) are used instead of light oil (1.0%S) and Bunker-C oil (4.0%S), to reduce sulfur dioxide exhaust in Seoul and whole country at a rate of 40% and 48% respectively. 2. The low sulfur oil application would be conducted in Seoul, the Seoul ambient concentration of SO^^2 in 1980 would be 0.056ppm from 0.094ppm. To maintain an air quality standard of SO^^2 concentration in Seoul city, 25% of coal consumption has to be substituted for city gas or Liquified Natural Gas, or 50% of coal has to be substituted for low sulfur oil. 3. By the low sulfur oil application the annual amounts of cost would be estinated to increase 142.51 billion won in 1983, 142.39 billion won in 1984, 113.6 billion won in 1985, and 139.69 billion won in 1986. Since 75% of total sulfur dioxide exhaust in Korea from high sulfur B-C oil, it is required that convert policy to low sulfur B-C oil urgently.restrictio

    ํ˜ˆ์••ํŒŒํ˜•๊ณผ ์‹ฌ๋ฐ•๋™ ๋ณ€์ด๋„๋ฅผ ์ด์šฉํ•œ ์‹ฌํ˜ˆ๊ด€ ์‹œ์Šคํ…œ์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    No full text
    Thesis(doctoral)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๋ฌผ๋ฆฌํ•™๋ถ€,2005.Docto

    ์‚ฌ๋žŒ ๊ฐ„์„ฑ์ƒ์„ธํฌ์ฃผ ๋ฐ ๋ฐฑ์„œ์—์„œ Magnesium lithospermate B์˜ ํ•ญ์„ฌ์œ ํ™” ํšจ๊ณผ

    No full text
    Dept. of Medicine/๋ฐ•์‚ฌ[ํ•œ๊ธ€] ๊ฐ„์„ฌ์œ ํ™” ํ˜„์ƒ์€ ๊ฐ„ ์กฐ์ง์—์„œ ๋‚˜ํƒ€๋‚˜๋Š” ์ƒ์ฒ˜์น˜์œ  ๊ณผ์ •์˜ ์ผ์ข…์œผ๋กœ์„œ ๊ฑฐ๋“ญ๋˜๋Š” ๊ฐ„์กฐ์ง์˜ ์†์ƒ๊ณผ ์žฌ์ƒ๊ณผ์ •์„ ํ†ตํ•˜์—ฌ ๊ฐ„๊ฒฝ๋ณ€์ฆ์ด ๋ฐœ์ƒ๋˜๊ณ  ์žˆ๋‹ค. ํ˜„์žฌ๊นŒ์ง€ ์ˆ˜๋งŽ์€ ํ•ญ์„ฌ์œ ํ™” ์น˜๋ฃŒ๊ฐ€ ์‹œ๋„๋˜์—ˆ์œผ๋‚˜ ํšจ๊ณผ์ ์ธ ํ•ญ์„ฌ์œ ํ™” ์•ฝ์ œ๋กœ ์‚ฌ์šฉ๋˜๋Š” ๋ฌผ์งˆ์€ ์—†๋‹ค. ์•ฝ์ดˆ์˜ ์ผ์ข…์ธ Salvia miltiorrhiza์˜ ์ถ”์ถœ๋ฌผ์€ ํŽ˜๋†€ํ™”ํ•ฉ๋ฌผ๋กœ ๊ตฌ์„ฑ๋˜์–ด ์žˆ์œผ๋ฉฐ ์ค‘๊ตญ์—์„œ ํ˜ˆ๊ด€๊ณ„ํ†ต์˜ ์งˆํ™˜ ์น˜๋ฃŒ์— ๋„๋ฆฌ ์ด์šฉ๋˜๊ณ  ์žˆ๋‹ค. Salvia miltiorrhiza์˜ ์ฃผ์š” ์„ฑ๋ถ„์ค‘์˜ ํ•˜๋‚˜์ธ magnesium lithospermate B (LAB)๋Š” ํ•ญ์‚ฐํ™” ํšจ๊ณผ๋กœ ์‹ ์žฅ๋ณดํ˜ธ ์„ฑ์งˆ์„ ๊ฐ€์ง€๊ณ  ์žˆ๋‹ค๊ณ  ์•Œ๋ ค์ ธ ์žˆ๋‹ค. ์ด์— ์ €์ž๋Š” ์‚ฌ๋žŒ ๊ฐ„์„ฑ์ƒ์„ธํฌ์ฃผ ๋ฐ ๋ฐฑ์„œ์—์„œ LAB์˜ ํ•ญ์„ฌ์œ ํ™” ํšจ๊ณผ๋ฅผ ์•Œ์•„๋ณด๊ณ ์ž ํ•˜์˜€๋‹ค. ๋™๋ฌผ ๊ฐ„์„ฌ์œ ํ™” ๋ชจ๋ธ์€ thioacetamide (TAA) ๋žซ๋“œ ๋ชจ๋ธ์„ ์‚ฌ์šฉํ•˜์˜€๋‹ค. ์‚ฌ๋žŒ ๊ฐ„์„ฑ์ƒ์„ธํฌ์ฃผ๋Š” ์ •์ƒ ์‚ฌ๋žŒ ๊ฐ„์กฐ์ง์œผ๋กœ๋ถ€ํ„ฐ ๊ฐ„์„ฑ์ƒ์„ธํฌ๋ฅผ ๋ถ„๋ฆฌํ•œ ๋’ค์— ๋ ˆํŠธ๋กœ๋ฐ”์ด๋Ÿฌ์Šค๋ฅผ ์ด์šฉํ•˜์—ฌ ๋ถˆ๋ฉธํ™”์‹œํ‚จ human telomerase reverse transcriptase (hTERT) ๊ฐ„์„ฑ์ƒ์„ธํฌ์ฃผ๋ฅผ ์‚ฌ์šฉํ•˜์˜€๋‹ค. ๋žซ๋“œ๋Š” ๊ฐ ๊ตฐ๋‹น 5๋งˆ๋ฆฌ์”ฉ 6๊ฐœ ๊ตฐ์œผ๋กœ ๋ถ„๋ฅ˜ํ•˜์˜€๋‹ค. ๋Œ€์กฐ๊ตฐ 5๋งˆ๋ฆฌ, LABํˆฌ์—ฌ๊ตฐ 5๋งˆ๋ฆฌ, TAA ํˆฌ์—ฌ๊ตฐ 10๋งˆ๋ฆฌ, TAA์™€ LAB ํˆฌ์—ฌ๊ตฐ 10๋งˆ๋ฆฌ๋กœ ํ•˜์—ฌ TAA ํˆฌ์—ฌ๊ตฐ 5๋งˆ๋ฆฌ์™€ TAA ๋ฐ LAB ๋™์‹œ ํˆฌ์—ฌ๊ตฐ 5๋งˆ๋ฆฌ๋Š” 8์ฃผ์— ํฌ์ƒํ•˜์˜€์œผ๋ฉฐ ๋‚˜๋จธ์ง€๋Š” 12์ฃผ์— ํฌ์ƒํ•˜์˜€๋‹ค. ๊ฐ„์กฐ์ง์„ Masson's trichrome ์—ผ์ƒ‰๊ณผ -smooth muscle actin ( -SMA) ๋ฉด์—ญํ™”ํ•™ ์—ผ์ƒ‰์„ ์‹œํ–‰ ํ›„ ์ปดํ“จํ„ฐ ์ด๋ฏธ์ง€ ๋ถ„์„์„ ํ†ตํ•˜์—ฌ ์—ผ์ƒ‰๋œ ๋ฉด์ ์„ ๊ตฌํ•˜์˜€๋‹ค. ๊ฐ„ ์†์ƒ ์ •๋„๋ฅผ ์ธก์ •ํ•˜๊ธฐ ์œ„ํ•˜์—ฌ ๋žซ๋“œ ํฌ์ƒ ์‹œ ์ˆ˜์ง‘ํ•œ ํ˜ˆ์•ก์—์„œ aspartate aminotransferase (AST)์™€ alanine transferase (ALT)๋ฅผ ์ธก์ •ํ•˜์˜€๋‹ค. ์—ญ์ „์‚ฌํšจ์†Œ ์ค‘ํ•ฉํšจ์†Œ์—ฐ์‡„๋ฐ˜์‘์„ ์ด์šฉํ•˜์—ฌ -SMA, transforming growth factor- (TGF- )์™€ type I collagen 1์˜ mRNA ์ˆ˜์น˜๋ฅผ ์ƒ๋Œ€์ ์œผ๋กœ ์ธก์ •ํ•˜์˜€๋‹ค. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)๋ฅผ ์ด์šฉํ•˜์—ฌ LAB์˜ ์„ธํฌ๋…์„ฑ ๋ฐ ์„ธํฌ ์ฆ์‹ ์–ต์ œ ํšจ๊ณผ๋ฅผ ์ธก์ •ํ•˜์˜€๋‹ค. ๊ณผ์‚ฐํ™”์ˆ˜์†Œ ์ฒ˜๋ฆฌ ํ›„ ๋ฐœ์ƒํ•˜๋Š” ์„ธํฌ ๋‚ด ๋ฐ˜์‘์„ฑ ์‚ฐ์†Œ๊ธฐ ์–ต์ œ ํšจ๊ณผ๋ฅผ ์ธก์ •ํ•˜์˜€์œผ๋ฉฐ tumor necrosis factor- (TNF- )๋ฅผ ์ฒ˜๋ฆฌ ํ›„ nuclear factor- B (NF- B)์˜ ์ „์‚ฌ ํ™œ์„ฑ๋„์˜ ์–ต์ œ ์ •๋„๋ฅผ ์ธก์ •ํ•˜์˜€๋‹ค. ๊ฐ„์„ฑ์ƒ์„ธํฌ์—์„œ ๋ถ„๋น„ํ•œ Iํ˜• ๊ต์›์งˆ ๋ฐ ์•ˆ์ง€์˜คํ…์‹  II์— ์ฒ˜๋ฆฌ ํ›„ extracellular signal-regulated kinases 1/2 (ERK 1/2)์˜ ํ‘œํ˜„์ด LAB์— ์˜ํ•ด ์–ต์ œ๋˜๋Š”์ง€ ์ธก์ •ํ•˜์˜€๋‹ค. ๋ฉด์—ญํ™”ํ•™์—ผ์ƒ‰ ๊ฒฐ๊ณผ TAA ๋‹จ๋… ํˆฌ์—ฌ ๊ตฐ์— ๋น„ํ•˜์—ฌ TAA์™€ LAB๋ฅผ ๋™์‹œ์— ํˆฌ์—ฌํ•œ ๊ตฐ์˜ ์—ผ์ƒ‰๋œ ๋ฉด์ ์ด ์œ ์˜ํ•˜๊ฒŒ ๋‚ฎ์•˜๋‹ค. 8์ฃผ TAA๊ตฐ์— ๋น„ํ•˜์—ฌ 8์ฃผ TAA์™€ LAB ๋™์‹œ ํˆฌ์—ฌ๊ตฐ์—์„œ AST, ALT ๋ชจ๋‘ ์˜๋ฏธ ์žˆ๊ฒŒ ๋‚ฎ์€ ์ˆ˜์น˜๋ฅผ ๋ณด์˜€์œผ๋‚˜ 12์ฃผ TAA๊ตฐ๊ณผ 12์ฃผ TAA์™€ LAB ๋™์‹œ ํˆฌ์—ฌ๊ตฐ์—์„œ๋Š” ์˜๋ฏธ ์žˆ๋Š” ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค. -SMA, TGF- ์™€ type I collagen 1์˜ ์ƒ๋Œ€์  mRNA ์ˆ˜์น˜๋Š” TAA๊ตฐ์— ๋น„ํ•ด TAA์™€ LAB ๋™์‹œ ํˆฌ์—ฌ๊ตฐ์—์„œ ์œ ์˜ํ•˜๊ฒŒ ๋‚ฎ์€ ๊ฒฐ๊ณผ๋ฅผ ๋ณด์˜€๋‹ค. MTT๋ฅผ ์ด์šฉํ•œ ๊ฐ„์„ฑ์ƒ์„ธํฌ ๋…์„ฑ ์‹คํ—˜ ๊ฒฐ๊ณผ LAB 40 ?M๊นŒ์ง€๋Š” ์„ธํฌ ๋…์„ฑ์„ ๋ณด์ด์ง€ ์•Š์•˜๋‹ค. PDGF ๋ฐ LAB๋ฅผ ๋™์‹œ์— ํˆฌ์—ฌํ•œ ๊ฐ„์„ฑ์ƒ์„ธํฌ๋Š” PDGF ๋‹จ๋… ํˆฌ์—ฌํ•œ ์„ธํฌ์— ๋น„ํ•˜์—ฌ ์ฆ์‹์ด ์–ต์ œ๋˜์—ˆ๋‹ค. ๊ณผ์‚ฐํ™”์ˆ˜์†Œ๋กœ ์ž๊ทนํ•˜์—ฌ ์„ธํฌ๋‚ด ๋ฐ˜์‘์„ฑ ์‚ฐ์†Œ๊ธฐ๋ฅผ ์ธก์ •ํ•œ ๊ฒฐ๊ณผ LAB๋กœ ์ „ ์ฒ˜๋ฆฌํ•œ ๊ฐ„์„ฑ์ƒ์„ธํฌ๊ฐ€ ์ „ ์ฒ˜๋ฆฌํ•˜์ง€ ์•Š์€ ์„ธํฌ์— ๋น„ํ•˜์—ฌ ๋ฐ˜์‘์„ฑ ์‚ฐ์†Œ๊ธฐ๊ฐ€ ์˜๋ฏธ์žˆ๊ฒŒ ์–ต์ œ๋˜๋Š” ์†Œ๊ฒฌ์„ ๋ณด์˜€๋‹ค. TNF- ๋ฅผ ์ฒ˜๋ฆฌํ•˜์˜€์„ ๋•Œ ๊ฐ„์„ฑ์ƒ์„ธํฌ์—์„œ NF- B์˜ ์ „์‚ฌ ํ™œ์„ฑ๋„๊ฐ€ ์ฆ๊ฐ€ํ•˜์˜€์œผ๋ฉฐ LAB๋ฅผ ์ „ ์ฒ˜๋ฆฌํ•œ ๊ฐ„์„ฑ์ƒ์„ธํฌ์—์„œ๋Š” NF- B์˜ ์ „์‚ฌ ํ™œ์„ฑ๋„๊ฐ€ ์˜๋ฏธ ์žˆ๊ฒŒ ๊ฐ์†Œํ•จ์„ ๋ณด์˜€๋‹ค. Western blot ๊ฒฐ๊ณผ LAB๋ฅผ ์ฒ˜๋ฆฌํ•œ ๊ฐ„์„ฑ์ƒ์„ธํฌ์—์„œ ๋ถ„๋น„ํ•œ Iํ˜• ๊ต์›์งˆ์˜ ์–‘์ด ์ฒ˜๋ฆฌํ•˜์ง€ ์•Š์€ ์„ธํฌ์™€ ๋น„๊ตํ•˜์—ฌ ์ ๊ฒŒ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์•ˆ์ง€์˜คํ…์‹  II๊ฐ€ ERK 1/2์˜ ์ธ์‚ฐํ™”๋ฅผ ์œ ๋„ํ•˜์˜€์œผ๋ฉฐ LAB๋ฅผ ์ „์ฒ˜๋ฆฌํ•œ ๊ฐ„์„ฑ์ƒ์„ธํฌ์—์„œ๋Š” ERK 1/2์˜ ํ‘œํ˜„์ด ๊ฐ์†Œ๋˜์—ˆ๋‹ค. LAB๋Š” ํ•ญ์‚ฐํ™” ์ž‘์šฉ์œผ๋กœ ERK ๊ฒฝ๋กœ ๋ฐ NF- B ์‹ ํ˜ธ์ „๋‹ฌ์ฒด๊ณ„ ์ฐจ๋‹จํ•˜์—ฌ ์‚ฌ๋žŒ ๊ฐ„์„ฑ์ƒ์„ธํฌ ์ฆ์‹ ๋ฐ ๊ต์›์งˆ ์ƒ์„ฑ์„ ์–ต์ œํ•˜์˜€์œผ๋ฉฐ TAA๋กœ ์œ ๋„ํ•œ ๋žซ๋“œ ๊ฐ„๊ฒฝ๋ณ€ ๋ชจ๋ธ์—์„œ ๊ฐ„์„ฌ์œ ํ™” ์–ต์ œ๋ฅผ ๋ณด์˜€๋‹ค. ๊ฒฐ๋ก ์ ์œผ๋กœ ์‚ฌ๋žŒ ๊ฐ„์„ฑ์ƒ์„ธํฌ์ฃผ ๋ฐ ๋žซ๋“œ ๊ฐ„๊ฒฝ๋ณ€ ๋ชจ๋ธ์—์„œ LAB์˜ ํ•ญ์„ฌ์œ ํ™” ํšจ๊ณผ๋ฅผ ํ™•์ธํ•˜์˜€๋‹ค. [์˜๋ฌธ] Hepatic fibrosis refers to a wound-healing response to a variety of insults, ultimately leading to cirrhosis. Recently, magnesium lithospermate B (LAB), one of the major active components from Salvia miltiorrhizae, has been given attention for its anti-fibrogenic effects. The antifibrotic effect of LAB in an experimental rat model was demonstrated. The aim of this study was to elucidate the antifibrogenic mechanism of LAB. Sprague-Dawley rats were divided into 6 groups: the control group (n = 5), control + LAB group (n = 5), TAA 8-week group (n = 5), TAA + LAB 8-week group (n = 5), TAA 12-week group (n=5) and TAA + LAB 12-week group (n = 5). The serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were tested. Masson's trichrome stain and ฮฑ-smooth muscle actin ( -SMA) stain of liver sections were analyzed. The relative levels of mRNA expressions of -SMA, transforming growth factor- (TGF- ) and type I collagen 1 were measured using real-time PCR. The human hepatic stellate cell (HSC) line was used for in vitro analysis. Cell cytotoxicity and proliferation were evaluated. Intracellular reactive oxygen species (ROS) formation was measured using H2DCFDA labeling. Nuclear factor- B (NF- B) transcriptional activation induced by tumor necrosis factor- (TNF- ) was measured using luciferase activity after virus vector transfer. Secreted type I collagen expression and phospho-extracellular signal regulated kinase (ERK) was evaluated using Western blots. LAB attenuated fibrosis in liver sections. The serum levels of AST and ALT were significantly lower in the TAA + LAB 8-week group than in the TAA 8-week group. LAB significantly decreased the mRNA levels of -SMA, TGF- and type I collagen 1. LAB treatment up to 40 ?M did not show any discernable toxicity. Platelet-derived growth factor (PDGF)-induced proliferation of HSCs was suppressed by LAB. H2O2-induced ROS formation in HSCs was decreased by LAB. Western blot demonstrated that LAB decreased type I collagen secretion and phospho-ERK expression in HSCs. In conclusion, the results of this study suggest that LAB may attenuate the activation of human HSCs through antioxidant activity. LAB demonstrated an antifibrogenic effect on TAA-induced cirrhosis in Sprague-Dawley ratsope

    ๋‹จ๋ฉดํ˜•์ƒ์ด ๋ถˆ์—ฐ์†์ ์œผ๋กœ ๋ณ€ํ•˜๋Š” ์›ํ˜•๋ง์˜ ์ง„๋™์— ๊ด€ํ•œ ์—ฐ๊ตฌ

    No full text
    Thesis (master`s)--์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› :๊ธฐ๊ณ„์„ค๊ณ„ํ•™๊ณผ,2000.Maste
    corecore